ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 78 filers reported holding ALX ONCOLOGY HLDGS INC in Q3 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,731 | -42.1% | 11,194 | -9.4% | 0.00% | – |
| Q2 2023 | $92,839 | +104.5% | 12,362 | +23.1% | 0.00% | – |
| Q1 2023 | $45,394 | -44.4% | 10,043 | +38.7% | 0.00% | – |
| Q4 2022 | $81,617 | -94.4% | 7,242 | -91.6% | 0.00% | – |
| Q1 2022 | $1,455,000 | -27.8% | 86,072 | -8.2% | 0.00% | -100.0% |
| Q4 2021 | $2,016,000 | +275.4% | 93,798 | +1190.9% | 0.00% | – |
| Q3 2021 | $537,000 | +107.3% | 7,266 | +53.4% | 0.00% | – |
| Q2 2021 | $259,000 | -81.5% | 4,738 | -75.0% | 0.00% | – |
| Q1 2021 | $1,397,000 | +34825.0% | 18,948 | +37796.0% | 0.00% | – |
| Q4 2020 | $4,000 | – | 50 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $715,272,000 | 67.97% |
| Logos Global Management LP | 3,156,981 | $232,796,000 | 22.72% |
| Vivo Capital, LLC | 4,220,048 | $311,186,000 | 10.94% |
| Foresite Capital Management IV, LLC | 785,945 | $57,956,000 | 6.94% |
| Foresite Capital Management V, LLC | 320,000 | $23,597,000 | 6.94% |
| Board of Trustees of The Leland Stanford Junior University | 518,822 | $38,258,000 | 3.38% |
| Cormorant Asset Management, LP | 881,770 | $65,022,000 | 1.45% |
| Redmile Group, LLC | 978,600 | $72,162,000 | 1.02% |
| SPHERA FUNDS MANAGEMENT LTD. | 130,351 | $9,612,000 | 0.74% |
| Artal Group S.A. | 525,000 | $38,714,000 | 0.68% |